Exosens SAS (EXENS.PA) Stock Price

Exosens SAS Price

CLOSED
59.10
​
Market closed

Over the last 5 years Exosens SAS grew revenue by 25.6% annually, reaching 468.20 M EUR. Earnings per share have declined at 7.4% per year over the last 3 years. For Exosens SAS, the net margin of 9.1% is up versus -89.6% a few years ago. At today's price the dividend yield works out to roughly 0.17%. The payout ratio is around 34% of earnings. The consensus 12-month price target for Exosens SAS is 55.59 EUR, about 5.9% below where the stock trades today. Of 18 analysts, 13 rate the stock a buy — an overall Buy consensus.

Exosens SAS stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Exosens SAS business model & stock analysis

Exosens SAS is a FR-based company operating in industry. The company is headquartered in Merignac, Nouvelle-Aquitaine. The company went IPO on 2024-06-07. EXOSENS SAS is a France-based company which is a manufacturer and seller of technologies in the field of particles and photo detection and imaging intended to serve space, research, defense and commercial clients. The firm designs, produces and markets electro-optic components and devices including sensors and optics for the detection and amplification of low light, radiation, and emissions. The company offers detectors and detection solutions: such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes to respond to complex issues in environment.

Frequently asked questions about Exosens SAS

Analysts currently set an average price target of 54.59 EUR for the Exosens SAS stock (median: 55.59 EUR), implying -7.6 % versus the latest price. The consensus is based on 18 analyst ratings.

19 analysts currently rate the Exosens SAS stock: 15 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Exosens SAS to generate revenue of 565.28 M EUR and earnings per share of 0.65 EUR.

The expected revenue of Exosens SAS is 565.28 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Exosens SAS is 95.32 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Exosens SAS is currently 90.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Exosens SAS stock.

The price-to-sales ratio (P/S) of Exosens SAS is currently 15.23. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Exosens SAS stock.

The Eulerpool Quality Score for Exosens SAS is 5/10.

The ISIN of Exosens SAS is FR001400Q9V2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Exosens SAS is EXENS.PA. The ticker symbol is used to trade Exosens SAS shares on the stock exchange.

Fair ValueTerminal
59.10 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website exosens.com
Country
Currency
EUR
Initial public offering
Jun 7, 2024
ISIN
FR001400Q9V2
Cusip
F33896105
Market capitalization
3.00 B EURMid Cap
52-Week Range
PEG
14.07
P/E ratio
P/Ee 2026
31.45
P/Ee 2027
24.41
P/Ee 2028
20.93
P/Ee 2029
17.75
P/Ee 2030
16.10
P/Se
15.23
EV/EBIT
31.30
P/B Ratio
6.73
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.97 %
Dividend
Dividend yield
0.17 %
Est. Dividend Yield
0.17 %
Payout Ratio
34.11 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
25.00 %
Last updated Oct 20, 2026, 9:54 AM

Exosens SAS Peer Group

All fundamentals and in-depth analysis of Exosens SAS

Our stock analysis for Exosens SAS stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Exosens SAS. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.